MedCity News July 17, 2024
Marissa Plescia

Thyme Care’s Series C funding round includes investments from Concord Health Partners, CVS Health Ventures, Town Hall Ventures, a16z Bio + Health, AlleyCorp, Echo Health Ventures, Frist Cressey Ventures and Foresite Capital.

Thyme Care, a value-based cancer care company, has secured $95 million in Series C funding, which it will use to grow its business, the company announced Tuesday.

Nashville, Tennessee-based Thyme Care, founded in 2020, partners with health plans, employers and risk-bearing providers in 31 states to support patients battling cancer. It offers care navigation services, technology and data insights and therapeutic interventions. The company helps patients understand their diagnosis, find a cancer doctor and receive clinical care between appointments. Patients also gain access to a team of providers,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Investments, Payment Models, Trends, Value Based
Related Articles:
Podcast: Medicare Shared Savings Program Mints $2B Win for Value-Based Care w/ Frank McStay
AHA, others urge Congress to act on alternative payment models, avoid physician payment cut
Value-Based Care Is a Four Layer Cake — Why Do We Only Focus on The Icing?
Cityblock Health Validates Value-Based Care Arrangement with 11.5% Payer Expense Reduction
Podcast: What Direction Will Alternative Payment Models Head Over the Next Four Years? 11/21/24

Share This Article